AVEOinactive
AVEO PHARMACEUTICALS, INC.
Biopharma developer (SEC filing verified)·Commercial·CEO: Winter Street
Boston
OncologyNephrology
Run AVEO PHARMACEUTICALS, INC. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available AVEO PHARMACEUTICALS, INC. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Regulatory
Governance
Frequently asked questions
Who is the CEO of AVEO PHARMACEUTICALS, INC.?
Winter Street Boston is the chief executive officer of AVEO PHARMACEUTICALS, INC. (AVEO).
What therapeutic areas does AVEO PHARMACEUTICALS, INC. focus on?
AVEO PHARMACEUTICALS, INC. develops therapies across Oncology, Nephrology.
923 companies304,846 SEC filings22,651 clinical trials100% citation-verification pass rate (7d)How we verify →
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.